Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 2/2011

01-03-2011

The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia

Auteurs: M. Riedel, I. Spellmann, R. Schennach-Wolff, M. Obermeier, R. Musil

Gepubliceerd in: Quality of Life Research | Uitgave 2/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

To develop and evaluate a self- and observer-rating scale on quality of life in patients suffering from schizophrenia with regard to the efficacy of atypical antipsychotics based on different dimensions and to apply within a pilot study.

Methods

Following review of existing scales and a prevalidation phase, the Riedel-Spellmann-Musil (RSM) scale was developed comprising 36 items assigned to different subscales. As reference scales, the Quality of Life Scale (QLS) and the Subjective Well-being Under Neuroleptic Treatment Scale—short version (SWN-K) were performed, psychopathology and adverse events were measured at all visits. Reliability was assessed using Cronbach’s alpha, Pearson’s correlation coefficients were used to assess construct validity, and Intraclass Correlation Coefficients (ICCs) were used for test–retest reliability. T tests were performed in normal distributed samples; otherwise Wilcoxon tests were used.

Results

One hundred and thirty-six patients were included in the study. Cronbach`s α was 0.917 for the self-rating and 0.915 for the interviewer-rating part. ICCs were >0.70 for all subscales. The self-rating part correlated strongly with the SWN-K and the observer part with the QLS. Changes in psychopathology over the study period and different levels of functioning were detected.

Conclusion

The RSM-scale is a new scale to assess the quality of life in different dimensions of patients with schizophrenia treated with antipsychotics and shows good internal consistency, test–retest reliability, construct and discriminant validity.
vorige artikel Understanding the relationships between health outcomes in generalized anxiety disorder clinical trials
volgende artikel Discrepancy in rating health-related quality of life of depression between patient and general population
Literatuur
1.
Moller, H. J. (2009). Standardised rating scales in Psychiatry: Methodological basis, their possibilities and limitations and descriptions of important rating scales. The World Journal of Biological Psychiatry, 10, 6–26.CrossRefPubMed
2.
Oliver, J. P., Huxley, P. J., Priebe, S., & Kaiser, W. (1997). Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Social Psychiatry and Psychiatric Epidemiology, 32, 76–83.CrossRefPubMed
3.
Voruganti, L. N., Heslegrave, R. J., & Awad, A. G. (1997). Quality of life measurement during antipsychotic drug therapy of schizophrenia. Journal of Psychiatry & Neuroscience, 22, 267–274.
4.
Young, A. S., Sullivan, G., Burnam, M. A., & Brook, R. H. (1998). Measuring the quality of outpatient treatment for schizophrenia. Archives of General Psychiatry, 55, 611–617.CrossRefPubMed
5.
Angermeyer, M., Kilian, R., Katschnig, H. (2006). Psychotropic medication and quality of life. In H. Katschnig, H. Freeman, & N. Sartorius (Eds.) Quality of life in mental disorders. Chichester, UK: Wiley.
6.
Bankole, A. O., Cohen, C. I., Vahia, I., Diwan, S., Kehn, M., & Ramirez, P. M. (2007). Factors affecting quality of life in a multiracial sample of older persons with schizophrenia. The American Journal of Geriatric Psychiatry, 15, 1015–1023.CrossRefPubMed
7.
Puschner, B., Born, A., Giessler, A., Helm, H., Leese, M., Bindman, J. P., et al. (2006). Adherence to medication and quality of life in people with schizophrenia: Results of a European multicenter study. Journal of Nervous and Mental Disease, 194, 746–752.CrossRefPubMed
8.
Hofer, A., Baumgartner, S., Edlinger, M., Hummer, M., Kemmler, G., Rettenbacher, M. A., et al. (2005). Patient outcomes in schizophrenia I: Correlates with sociodemographic variables, psychopathology, and side effects. European Psychiatry, 20, 386–394.CrossRefPubMed
9.
Malik, P. (2007). Sexual dysfunction in schizophrenia. Current Opinion in Psychiatry, 20, 138–142.CrossRefPubMed
10.
Olfson, M., Uttaro, T., Carson, W. H., & Tafesse, E. (2005). Male sexual dysfunction and quality of life in schizophrenia. Journal of Clinical Psychiatry, 66, 331–338.CrossRefPubMed
11.
Ritsner, M. S. (2007). Predicting quality of life impairment in chronic schizophrenia from cognitive variables. Quality of Life Research, 16, 929–937.CrossRefPubMed
12.
Mittal, D., Davis, C. E., Depp, C., Pyne, J. M., Golshan, S., Patterson, T. L., et al. (2006). Correlates of health-related quality of well-being in older patients with schizophrenia. Journal of Nervous and Mental Disease, 194, 335–340.CrossRefPubMed
13.
Alptekin, K., Akvardar, Y., Kivircik Akdede, B. B., Dumlu, K., Isik, D., Pirincci, F., et al. (2005). Is quality of life associated with cognitive impairment in schizophrenia? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29, 239–244.CrossRefPubMed
14.
Meltzer, H. Y. (2004). Cognitive factors in schizophrenia: Causes, impact, and treatment. CNS Spectrums, 9, 15–24.PubMed
15.
Sota, T. L., & Heinrichs, R. W. (2004). Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Comprehensive Psychiatry, 45, 415–421.CrossRefPubMed
16.
Fujii, D. E., Wylie, A. M., & Nathan, J. H. (2004). Neurocognition and long-term prediction of quality of life in outpatients with severe and persistent mental illness. Schizophrenia Research, 69, 67–73.CrossRefPubMed
17.
Gorna, K., Jaracz, K., Wrzyszczynska, L., & Rybakowski, F. (2007). Quality of life and depression in schizophrenic patients. Advances in Medical Sciences, 52(Suppl 1), 108–111.PubMed
18.
Xiang, Y. T., Weng, Y. Z., Leung, C. M., Tang, W. K., & Ungvari, G. S. (2007). Impact of sociodemographic and clinical factors on subjective quality of life in schizophrenia patients in Beijing, China. Journal of Nervous and Mental Disease, 195, 853–856.CrossRefPubMed
19.
Heider, D., Angermeyer, M. C., Winkler, I., Schomerus, G., Bebbington, P. E., Brugha, T., et al. (2007). A prospective study of Quality of life in schizophrenia in three European countries. Schizophrenia Research, 93, 194–202.CrossRefPubMed
20.
Yeung, F. K., & Chan, S. H. (2006). Clinical characteristics and objective living conditions in relation to quality of life among community-based individuals of schizophrenia in Hong Kong. Quality of Life Research, 15, 1459–1469.CrossRefPubMed
21.
Caron, J., Lecomte, Y., Stip, E., & Renaud, S. (2005). Predictors of quality of life in schizophrenia. Community Mental Health Journal, 41, 399–417.CrossRefPubMed
22.
Eklund, M., & Leufstadius, C. (2007). Relationships between occupational factors and health and well-being in individuals with persistent mental illness living in the community. Canadian Journal of Occupational Therapy, 74, 303–313.
23.
Nordt, C., Muller, B., Rossler, W., & Lauber, C. (2007). Predictors and course of vocational status, income, and quality of life in people with severe mental illness: A naturalistic study. Social Science and Medicine, 65, 1420–1429.CrossRefPubMed
24.
Browne, S. (1999). Rehabilitation programmes and quality of life in severe mental illness. International Journal of Social Psychiatry, 45, 302–309.CrossRefPubMed
25.
Holzner, B., Kemmler, G., & Meise, U. (1998). The impact of work-related rehabilitation on the quality of life of patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 33, 624–631.CrossRefPubMed
26.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington DC: American Psychiatric Association.
27.
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T., Jr. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10, 388–398.PubMed
28.
Naber, D., Moritz, S., Lambert, M., Pajonk, F. G., Holzbach, R., Mass, R., et al. (2001). Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs. Schizophrenia Research, 50, 79–88.CrossRefPubMed
29.
Naber, D. (1995). A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. International Clinical Psychopharmacology, 10(Suppl 3), 133–138.PubMed
30.
Guy, W. (1976). Clinical Global Impressions. ECDEU assessment manual for psychopharmacology. Rockville, MD revised: National Institute of Mental Health.
31.
Endicott, J., Spitzer, R. L., Fleiss, J. L., & Cohen, J. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766–771.PubMed
32.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276.PubMed
33.
Chouinard, G., Ross-Chouinard, A., Annable, L., & Jones, B. (1980). The extrapyramidal symptom rating scale. The Canadian Journal of Neurological Sciences, 7, 233.
34.
Lingjaerde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987). The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica. Supplementum, 334, 1–100.CrossRefPubMed
35.
Kawata, A. K., & Revicki, D. A. (2008). Reliability and validity of the social integration survey (SIS) in patients with schizophrenia. Quality of Life Research, 17, 123–135.CrossRefPubMed
36.
Auquier, P., Simeoni, M. C., Sapin, C., Reine, G., Aghababian, V., Cramer, J., et al. (2003). Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: The S-QoL. Schizophrenia Research, 63, 137–149.CrossRefPubMed
37.
R Development Core Team. (2008). A language and environment for statistical computing. URL http/​:​www.​R-project.​org. Vienna, Austria: Foundation for Statistical Computing. Ref Type: Computer Program.
38.
McHorney, C. A., Ware, J. E., Jr., Lu, J. F., & Sherbourne, C. D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32, 40–66.CrossRefPubMed
39.
Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York, Mc: Graw-Hill.
40.
Kusel, Y., Laugharne, R., Perrington, S., McKendrick, J., Stephenson, D., Stockton-Henderson, J., et al. (2007). Measurement of quality of life in schizophrenia: A comparison of two scales. Social Psychiatry and Psychiatric Epidemiology, 42, 819–823.CrossRefPubMed
41.
Bengtsson-Tops, A., Hansson, L., Sandlund, M., Bjarnason, O., Korkeila, J., Merinder, L., et al. (2005). Subjective versus interviewer assessment of global quality of life among persons with schizophrenia living in the community: A Nordic multicentre study. Quality of Life Research, 14, 221–229.CrossRefPubMed
42.
Van, N. C., Schene, A. H., Koeter, M. W., & Huxley, P. J. (2001). The Lancashire Quality of Life Profile: Modification and psychometric evaluation. Social Psychiatry and Psychiatric Epidemiology, 36, 36–44.CrossRef
43.
Kleinman, L., Lieberman, J., Dube, S., Mohs, R., Zhao, Y., Kinon, B., et al. (2009). Development and psychometric performance of the schizophrenia objective functioning instrument: An interviewer administered measure of function. Schizophrenia Research, 107, 275–285.CrossRefPubMed
Metagegevens
Titel
The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia
Auteurs
M. Riedel
I. Spellmann
R. Schennach-Wolff
M. Obermeier
R. Musil
Publicatiedatum
01-03-2011
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 2/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9744-z

Andere artikelen Uitgave 2/2011

Quality of Life Research 2/2011 Naar de uitgave

OriginalPaper

Understanding the relationships between health outcomes in generalized anxiety disorder clinical trials

OriginalPaper

Comparison of Arab breast cancer survivors and healthy controls for spousal relationship, body image, and emotional distress

OriginalPaper

Measurement properties of a multicultural weight-specific quality-of-life instrument for children and adolescents

OriginalPaper

Missing data methods for dealing with missing items in quality of life questionnaires. A comparison by simulation of personal mean score, full information maximum likelihood, multiple imputation, and hot deck techniques applied to the SF-36 in the French 2003 decennial health survey

OriginalPaper

Comparison of the short-term health-related quality of life in patients with esophageal cancer with different routes of gastric tube reconstruction after minimally invasive esophagectomy

Brief Communication

Validation of the Fatigue Impact Scale in Hungarian patients with multiple sclerosis